Is Bevacizumab 400 mg Chemotherapy or Immunotherapy?

Bevacizumab monoclonal antibody targets vascular endothelial growth factor (VEGF). Plays a very important role in inhibiting angiogenesis. Approved in 2004. Treats lung, colorectal and breast cancer. Despite its varied use, there is a certain intense discussion going on behind it can be used as chemotherapy or immunotherapy. There is evidence that suggests bevacizumab might work similarly to chemotherapy. Whereas others suggest it will enhance the immune cells against the cancer cells. This blog will make you understand bevacizumab’s mechanism of action, and the evidence supporting its classification as either chemotherapy or immunotherapy with Bevacizumab 400 mg prices.

Understanding chemotherapy and immunotherapy

– How chemotherapy works

Chemotherapy is a type of cancer treatment involving drug use to kill cancer cells.These drugs attack rigorously dividing cancer cells. But, it also affects cells of the hair follicles and digestive tract

– How immunotherapy works

Immunotherapy is a cancer treatment which works by recharging the body’s immune system to fight tumors. Drugs are used to stimulate the immune system to recognize, surround and kill cancer cells. Use the patient’s cells and the immune system to target and destroy cancer cells.

Bevacizumab mechanism of action

– Preventing the formation of new blood vessels

Bevacizumab inhibits angiogenesis. This involves stopping the formation of new blood vessels. This process is very important since tumors need a supply of blood to grow and survive. By blocking or inhibiting this process, it will starve the tumor cells to starve. This is because the tumor cells receive oxygen and nutrients from such a blood vessel network.

– Targeting VEGF

Bevacizumab targets VEGF specifically. This protein plays a key part in angiogenesis. VEGF will stimulate the growth and survival of blood vessels, especially those supplying tumors. Through blocking it, Bevacizumab prevents or hinders new blood vessel formation alongside disrupting the existing blood supply to the tumor

Evidence Supporting Bevacizumab 400 mg Use as Chemotherapy

– Studies supporting use as chemotherapy

Although bevacizumab is not traditionally designed for use as a chemotherapy drug,it has the same effects. In certain studies, when it is combined with chemotherapy, it has effective nature as compared to standard chemotherapy alone.

– Clinical importance along with chemotherapy

Bevacizumab 400 mg is the first line of combined treatment for colorectal, lung, and ovarian cancer. Kept under chemotherapy use. But, it is very necessary to understand that it has the same effects as traditional chemotherapy. These are nausea and headache.

Evidence Supporting Bevacizumab Use as Immunotherapy

Used as immunotherapy other than chemotherapy. This drug has the ability to change the immune system.. On the other hand, it will increase the infiltration of immune cells into tumor tissue. This will increase the outcome for patients. There are now increasing studies to validate its use as an immunotherapies. For instance, researchers have found that this medication with immune checkpoint inhibitors can improve response rates in cancer. This suggests that bevacizumab can overcome tumor resistance to immunotherapies.

Price as outcome of care

Bevacizumab 400mg price are due to research and development that went into creating this medicine. Other factors behind the increasing bevacizumab 400 mg prices are maintenance and monitoring for patient safety. There are pharma companies offering patient assistance programs or insurance coverage to cover the cost. So, while it is an expensive medication, it is important to discuss options with a healthcare provider and explore options to get availability to these potentially life-saving drugs.